Hereditary hemorrhagic telangiectasia associated epistaxis in the Norwegian population. Severity, impact on the quality of life and new treatment modality
Metadata
Show metadataAppears in the following Collection
- Institutt for klinisk medisin [10950]
Abstract
No abstract.List of papers
Paper I: Al-Deen S, Bachmann-Harildstad G. A grading scale for epistaxis in hereditary haemorrhagic teleangectasia. Rhinology. 2008 Dec;46(4):281-4. The paper is removed from the thesis in DUO due to publisher restrictions. |
Paper II: Dheyauldeen S, Abdelnoor M, Bachmann-Harildstad G. The natural history of epistaxis in patients with hereditary hemorrhagic telangiectasia in the Norwegian population: a cross-sectional study. Am J Rhinol Allergy. 2011 Jul-Aug;25(4):214-8. The paper is removed from the thesis in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.2500/ajra.2011.25.3616 |
Paper III: Geirdal AØ, Dheyauldeen S, Bachmann-Harildstad G, Heimdal K. Quality of life in patients with hereditary hemorrhagic telangiectasia in Norway: a population based study. Am J Med Genet A. 2012 Jun;158A(6):1269-78. The paper is removed from the thesis in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1002/ajmg.a.35309 |
Paper IV: Dheyauldeen S, Østertun Geirdal A, Osnes T, Vartdal LS, Dollner R. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose. Laryngoscope. 2012 Jun;122(6):1210-4. The paper is removed from the thesis in DUO due to publisher restrictions. The published version is available at: https://doi.org/10.1002/lary.23303 |